Citigroup
C
Chevron
CVX
The Kraft Heinz
KHC
DaVita
DVA
Apple
AAPL
US Stock MarketDetailed Quotes
ACRS Aclaris Therapeutics
- 2.570
- +0.060+2.39%
Close Jan 17 16:00 ET
- 2.550
- -0.020-0.78%
Post 20:01 ET
275.04MMarket Cap-4.94P/E (TTM)
2.590High2.460Low506.94KVolume2.540Open2.510Pre Close1.29MTurnover0.68%Turnover RatioLossP/E (Static)107.02MShares5.17052wk High2.11P/B191.03MFloat Cap0.95252wk Low--Dividend TTM74.33MShs Float33.880Historical High--Div YieldTTM5.18%Amplitude0.590Historical Low2.536Avg Price1Lot Size
Aclaris Therapeutics News
Aclaris Therapeutics Analyst Ratings
H.C. Wainwright Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating, Announces Target Price $20
Jefferies Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $7
Aclaris Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating
Stifel Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating, Raises Target Price to $5
Stifel Nicolaus Remains a Hold on Aclaris Therapeutics (ACRS)
Cantor Fitzgerald Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating
Aclaris Therapeutics Price Target Raised to $7.00/Share From $2.00 by Leerink Partners
Aclaris Therapeutics Raised to Outperform From Market Perform by Leerink Partners
A Quick Look at Today's Ratings for Aclaris Therapeutics(ACRS.US), With a Forecast Between $3 to $13
Jefferies Upgrades Aclaris Therapeutics to Buy, Price Target Is $7
Promising Potential of Aclaris Therapeutics' BSI-045B and Pipeline Elevates Buy Rating
Piper Sandler: Authorized trade is transformative. Target price for Aclaris (ACRS.US) is significantly raised to $13.
Aclaris Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), McKesson (MCK) and Enhabit, Inc (EHAB)
Aclaris Therapeutics: Hold Rating Amid Mixed Trial Outcomes and Strategic Uncertainties
Stifel Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating, Raises Target Price to $3
Stifel Nicolaus Sticks to Its Hold Rating for Aclaris Therapeutics (ACRS)
BTIG Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating
H.C. Wainwright Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.